Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Birte Pedersen, Alment praktiserende læge ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.2% 2.6% 2.4% 2.1% 2.1% 3.5% 24.1% 23.7%   Credit score (0-100)   58 64 65 69 68 51 3 3   Credit rating   BBB BBB BBB A A BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,274 1,946 2,053 1,995 2,128 1,923 0.0 0.0   EBITDA   663 645 791 670 873 665 0.0 0.0   EBIT   549 644 697 577 777 569 0.0 0.0   Pre-tax profit (PTP)   542.9 641.4 685.8 573.6 768.2 559.8 0.0 0.0   Net earnings   422.8 499.8 531.6 449.8 598.5 435.8 0.0 0.0   Pre-tax profit without non-rec. items   543 641 686 574 768 560 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Tangible assets total   147 426 331 277 181 84.6 0.0 0.0   Shareholders equity total   569 769 801 750 849 585 4.8 4.8   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   973 1,103 1,136 1,154 1,349 872 4.8 4.8   Net Debt   -647 -496 -646 -713 -973 -585 -4.8 -4.8     See the entire balance sheet 1000.0 Volume  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,274 1,946 2,053 1,995 2,128 1,923 0.0 0.0   Gross profit growth   0.0% -40.6% 5.5% -2.9% 6.7% -9.6% -100.0% 0.0%   Employees   5 3 3 3 3 3 0 0   Employee growth %   0.0% -40.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   973 1,103 1,136 1,154 1,349 872 5 5   Balance sheet change%   0.0% 13.3% 3.0% 1.6% 16.9% -35.4% -99.5% 0.0%   Added value   548.9 643.9 696.5 577.2 776.5 569.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   33 278 -190 -147 -192 -192 -85 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.8% 33.1% 33.9% 28.9% 36.5% 29.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   56.4% 62.0% 62.2% 50.4% 62.0% 51.2% 0.0% 0.0%   ROI %   96.4% 94.8% 86.6% 71.1% 90.7% 76.2% 0.0% 0.0%   ROE %   74.3% 74.7% 67.7% 58.0% 74.8% 60.8% 0.0% 0.0%   1000.0 Solidity  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Equity ratio %   58.5% 69.7% 70.5% 65.0% 62.9% 67.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -97.5% -76.9% -81.6% -106.3% -111.5% -88.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Quick Ratio   2.0 2.1 3.5 3.3 3.9 4.1 0.0 0.0   Current Ratio   2.0 2.1 3.5 3.3 3.9 4.1 0.0 0.0   Cash and cash equivalent   646.6 496.1 645.9 712.5 972.9 585.3 0.0 0.0   1000.0 Capital use efficiency  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   394.5 335.5 556.1 594.7 846.4 575.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2017/4 2017 2018/4 2018 2019/4 2019 2020/4 2020 2021/4 2021 2022/4 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   110 215 232 192 259 190 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   133 215 264 223 291 222 0 0   EBIT / employee   110 215 232 192 259 190 0 0   Net earnings / employee   85 167 177 150 200 145 0 0